Drug-induced extrapyramidal syndromes

J R Coll Physicians Lond. 1970 Oct;5(1):87-98.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Factors
  • Antipsychotic Agents / adverse effects
  • Basal Ganglia Diseases / chemically induced*
  • Basal Ganglia Diseases / physiopathology
  • Basal Ganglia Diseases / prevention & control
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Dystonia Musculorum Deformans / chemically induced
  • Dystonia Musculorum Deformans / diagnosis
  • Dystonia Musculorum Deformans / drug therapy
  • Dystonia Musculorum Deformans / physiopathology
  • Dystonia Musculorum Deformans / prevention & control
  • Female
  • Humans
  • Male
  • Movement Disorders / chemically induced
  • Movement Disorders / prevention & control
  • Parasympatholytics / therapeutic use
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy
  • Parkinson Disease, Secondary / physiopathology
  • Parkinson Disease, Secondary / prevention & control
  • Phenothiazines
  • Sex Factors
  • Tranquilizing Agents / adverse effects*

Substances

  • Antipsychotic Agents
  • Central Nervous System Stimulants
  • Parasympatholytics
  • Phenothiazines
  • Tranquilizing Agents